VRCA

Conviction 18HealthcareScan · Mon, Aug 10, 2026

Bullish harami

VRCA$5.27+3.74%

ResistanceSupportVol 14

Vol MA14 42.38K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Verrica Pharmaceuticals Inc.PHARMACEUTICAL PREPARATIONSwww.verrica.com ↗

Price5.27

Change+3.74%

Gap+1.97%

Rel volume1.27×

Avg volume36.3K

Avg $ vol194.34K

SMA 205.41

SMA 505.78

SMA 2006.12

Price vs 50-8.80%

Price vs 200-13.93%

MA stackbearish

50/200 cross—

Supertrenddown · 6.48

RSI (14)44

MACD hist0.01

MACD crossbull · 3d

Stoch %K / %D49 / 41

ADX (14)13

+DI / −DI17 / 25

RSI divergence—

MACD divergence—

ATR %+8.43%

ADR %7.51%

52w high9.10

52w low3.28

From 52w high-42.09%

Above 52w low+60.67%

New 52w highNo

SqueezeOn · 3d

Bollinger width15.81%

%B0.34

Donchian pos41.01%

Donchian high6.09

Donchian low4.70

AVWAP (52w high)7.11

vs AVWAP high-25.84%

AVWAP (52w low)6.84

vs AVWAP low-22.90%

OBV trendFlat

Chaikin MF (20)-0.11

Today vs 20d1.27×

Avg vol (14d)42.38K

Avg vol (20d)36.3K

Avg $ vol (20d)194.34K

Market cap90.53M

RS 3m (vs SPY)-44.05%

RS 6m (vs SPY)-37.26%

RS line new highNo

Trend template3/8

Technical rank14.6

1 week+0.38%

1 month-15.81%

3 months-34.04%

6 months-23.73%

1 year-13.75%

YTD-36.51%

P/E-5.06

P/B21.02

P/S11.97

P/FCF-5.14

EPS-1.68

Div yield—

ROE-415.28%

ROA-49.66%

Debt/Eq0.00

Current1.45

EV/EBITDA—

Gross margin—

Net margin-236.40%

Rev growth47.66%

EPS growth76.64%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value79.33M

Revenue12.7M

Net income-13.15M

Gross profit—

Free cash flow-17.63M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out17.18M

Employees76

ListedFri, Jun 15, 2018

Free float5.63M

Float %35.2%

Short interest315.76K

Days to cover11.1d

Short volume31.9%

Squeeze score40 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.54

Last surprise—

Setup gradeD

Conviction18 / 100

Pattern quality—

Tech rank14.6 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VRCA

All disclosures →

No recent disclosed trades by Congress in VRCA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VRCA · 7 buys

Insider	Side	Shares	Value	Traded	Filed
Eichenfield Lawrence Director · Stock Option (right to buy) · 2026-06-05	Grant	16K	$0	2026-06-05	2026-06-09
PRYGOCKI MARK A SR Director · Stock Option (right to buy) · 2026-06-05	Grant	16K	$0	2026-06-05	2026-06-09
Corcoran Gavin Director · Stock Option (right to buy) · 2026-06-05	Grant	16K	$0	2026-06-05	2026-06-09
Rosenberg Noah L. CMO · Employee Stock Option (right to buy) · 2026-06-05	Grant	233.84K	$0	2026-06-05	2026-06-09
Rieger Jayson CEO and President · Employee Stock Option (right to buy) · 2026-06-05	Grant	512.27K	$0	2026-06-05	2026-06-09
Nguyen Diem Director · Stock Option (right to buy) · 2026-06-05	Grant	16K	$0	2026-06-05	2026-06-09
Zawitz David Chief Operating Officer · Employee Stock Option (right to buy) · 2026-06-05	Grant	171.34K	$0	2026-06-05	2026-06-09

SEC filings

EDGAR filings in VRCA · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.